fda warning on semaglutide warns about overdoses, adverse effects FDA Approves Semaglutide to Prevent

In the randomized Semaglutide Treatment Effect in People with Obesity (STEP) 1 trial (intent to treat: 1,961 adults with overweight or obesity without T2D), once-weekly subcutaneous semaglutide 2.4 mg resulted in greater weight loss compared with placebo over a 68-week period (estimated treatment difference 12.4 percentage points, 95% confidence interval (CI) 13.4, 11.5

Which leads me to believe that Z-Pack fried my hormones and caused an anovulatory cycle, just like the info in the article says

Immune System Support Boosts immune response, helping your body fight illness and maintain optimal health

A judge stopped three (more) companies from delivering imported medicines to U.S

It promotes the formation of new blood vessels, which improves nutrient delivery to healing tissues